Chemical Compound
Sodium [5-[(1S,2S,3S)-4-[[(2S,3R)-5-amino-1-[(2S,3S,4S)-2-carbamoyl-3-hydroxy-4-methylpyrrolidin-1-yl]-3-hydroxy-1,5-dioxopentan-2-yl]amino]-3-[[(2S,4R)-1-[(2S,3R)-2-[[(2S,4R)-4,5-dihydroxy-1-[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]-4-hydroxypyrrolidine-2-carbonyl]amino]-1,2-dihydroxy-4-oxobutyl]-2-hydroxyphenyl] sulfate
CAS Registry Number
539823-82-0
Primary record
Sodium [5-[(1S,2S,3S)-4-[[(2S,3R)-5-amino-1-[(2S,3S,4S)-2-carbamoyl-3-hydroxy-4-methylpyrrolidin-1-yl]-3-hydroxy-1,5-dioxopentan-2-yl]amino]-3-[[(2S,4R)-1-[(2S,3R)-2-[[(2S,4R)-4,5-dihydroxy-1-[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]-4-hydroxypyrrolidine-2-carbonyl]amino]-1,2-dihydroxy-4-oxobutyl]-2-hydroxyphenyl] sulfate
- 库存
- 9,079 克
- 纯度
- 98.7 %
- CAS
- 539823-82-0
化合物标识与属性
- CAS
- 539823-82-0
- PubChem CID
- 171380930
- SMILES
- CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N4[C@@H](C[C@H](C4O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N5C[C@@H](C[C@H]5C(=O)N[C@@H]([C@@H]([C@H](C6=CC(=C(C=C6)O)OS(=O)(=O)[O-])O)O)C(=O)N[C@@H]([C@@H](CC(=O)N)O)C(=O)N7C[C@@H]([C@@H]([C@H]7C(=O)N)O)C)O.[Na+]
- Canonical SMILES
- CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N4C(O)[C@H](O)C[C@H]4C(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N4C[C@H](C)[C@H](O)[C@H]4C(N)=O)[C@H](O)CC(N)=O)[C@H](O)[C@@H](O)c4ccc(O)c(OS(=O)(=O)[O-])c4)[C@@H](C)O)cc3)no2)cc1.[Na+]
名称与同义词
- Micafungin open ring Impurity
- Micafungin Open-ring Analog
- 9C62ZSN8N2
- Micafungin Open-Ring Analog Sodium salt
- Micafungin Open Ring Analog (Na Salt)
- 539823-82-0
- B1370-071106
- (3S,4S)-(4R)-4,5-Dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-L-prolinamide sodium
- 5-((1S,2S,3S)-4-(((2S,3R)-5-Amino-1-((2S,3S,4S)-2-carbamoyl-3-hydroxy-4-methylpyrrolidin-1-yl)-3-hydroxy-1,5-dioxopentan-2-yl)amino)-3-((2S,4R)-1-(((2S,4R)-4,5-dihydroxy-1-(4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoyl)pyrrolidine-2-carbonyl)-L-threonyl)-4-hydroxypyrrolidine-2-carboxamido)-1,2-dihydroxy-4-oxobutyl)-2-hydroxyphenyl hydrogen sulfate, Sodium Salt
- L-Prolinamide, (4R)-4,5-dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-, sodium salt (1:1), (3S,4S)-
- L-Prolinamide, (4R)-4,5-dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-, sodium salt, (3S,4S)-
- Sodium [5-[(1S,2S,3S)-4-[[(2S,3R)-5-amino-1-[(2S,3S,4S)-2-carbamoyl-3-hydroxy-4-methylpyrrolidin-1-yl]-3-hydroxy-1,5-dioxopentan-2-yl]amino]-3-[[(2S,4R)-1-[(2S,3R)-2-[[(2S,4R)-4,5-dihydroxy-1-[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]-4-hydroxypyrrolidine-2-carbonyl]amino]-1,2-dihydroxy-4-oxobutyl]-2-hydroxyphenyl] sulfate